Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1996 Sep;34(9):2143–2147. doi: 10.1128/jcm.34.9.2143-2147.1996

Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas' disease.

E S Umezawa 1, M S Nascimento 1, N Kesper Jr 1, J R Coura 1, J Borges-Pereira 1, A C Junqueira 1, M E Camargo 1
PMCID: PMC229206  PMID: 8862574

Abstract

Immunoblotting with trypomastigote excreted-secreted antigens (TESA blot) of Trypanosoma cruzi was evaluated as a method for diagnosis of chronic and acute phases as well as congenital (in newborn children) Chagas' disease. Serum samples from acute-phase and congenital infections were considered to be positive when they reacted with ladder-like bands of 130- to 200-kDa antigens, recognized by immunoglobulin M (IgM) and IgG antibodies, while IgG from chronic-phase sera recognized a broad band antigen of 150 to 160 kDa. Nonchagasic sera were not reactive to these antigens. The study was carried out on 512 patients, 111 of whom were nonchagasic but included cases of leishmaniasis or other pathologies, and 401 chagasic patients. The latter group comprised 361 chronic cases, 36 acute cases, and 4 congenital cases in newborn children. Among the chronic cases, 256 were from areas in which T. cruzi is endemic but which differed widely in the pathogenic expression of T. cruzi infection and in parasitemia levels. These patients at the same time showed a broad range of low, medium, and high reactivity to conventional enzyme-linked immunosorbent assays and indirect immunofluorescence serotests for Chagas' disease. For these reasons they may better represent the universe of chagasic patients than would a sample of highly reactive sera obtained from chagasic patients in a single area endemic for T. cruzi. All acute and congenital cases showed positivity in the IgM and IgG TESA blots, while chronic cases were 100% positive for IgG antibodies. In nonchagasic sera, including 30 cases of visceral and muco-cutaneous leishmaniasis, the specificity index was 1.000, and no cross-reactions were observed. The TESA blot thus seems to be useful as a sensitive and specific diagnostic assay in cases of suspected acute or congenital T. cruzi infection and as a general confirmatory test for conventional Chagas' disease serology.

Full Text

The Full Text of this article is available as a PDF (430.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Affranchino J. L., Ibañez C. F., Luquetti A. O., Rassi A., Reyes M. B., Macina R. A., Aslund L., Pettersson U., Frasch A. C. Identification of a Trypanosoma cruzi antigen that is shed during the acute phase of Chagas' disease. Mol Biochem Parasitol. 1989 May 15;34(3):221–228. doi: 10.1016/0166-6851(89)90050-9. [DOI] [PubMed] [Google Scholar]
  2. Camargo M. E., Amato Neto V. Anti-Trypanosoma cruzi IgM antibodies as serological evidence of recent infection. Rev Inst Med Trop Sao Paulo. 1974 Jul-Aug;16(4):200–202. [PubMed] [Google Scholar]
  3. Chiller T. M., Samudio M. A., Zoulek G. IgG antibody reactivity with Trypanosoma cruzi and Leishmania antigens in sera of patients with Chagas' disease and leishmaniasis. Am J Trop Med Hyg. 1990 Dec;43(6):650–656. doi: 10.4269/ajtmh.1990.43.650. [DOI] [PubMed] [Google Scholar]
  4. Freilij H., Altcheh J. Congenital Chagas' disease: diagnostic and clinical aspects. Clin Infect Dis. 1995 Sep;21(3):551–555. doi: 10.1093/clinids/21.3.551. [DOI] [PubMed] [Google Scholar]
  5. Gonçalves M. F., Umezawa E. S., Katzin A. M., de Souza W., Alves M. J., Zingales B., Colli W. Trypanosoma cruzi: shedding of surface antigens as membrane vesicles. Exp Parasitol. 1991 Jan;72(1):43–53. doi: 10.1016/0014-4894(91)90119-h. [DOI] [PubMed] [Google Scholar]
  6. Guhl F., Hudson L., Marinkelle C. J., Jaramillo C. A., Bridge D. Clinical Trypanosoma rangeli infection as a complication of Chagas' disease. Parasitology. 1987 Jun;94(Pt 3):475–484. doi: 10.1017/s0031182000055827. [DOI] [PubMed] [Google Scholar]
  7. Jazín E. E., Luquetti A. O., Rassi A., Frasch A. C. Shift of excretory-secretory immunogens of Trypanosoma cruzi during human Chagas' disease. Infect Immun. 1991 Jun;59(6):2189–2191. doi: 10.1128/iai.59.6.2189-2191.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Junqueira A. C., Chiari E., Wincker P. Comparison of the polymerase chain reaction with two classical parasitological methods for the diagnosis of Chagas disease in an endemic region of north-eastern Brazil. Trans R Soc Trop Med Hyg. 1996 Mar-Apr;90(2):129–132. doi: 10.1016/s0035-9203(96)90111-x. [DOI] [PubMed] [Google Scholar]
  9. Lorca M., Gonzalez A., Veloso C., Reyes V., Vergara U. Immunodetection of antibodies in sera from symptomatic and asymptomatic Chilean Chagas' disease patients with Trypanosoma cruzi recombinant antigens. Am J Trop Med Hyg. 1992 Jan;46(1):44–49. doi: 10.4269/ajtmh.1992.46.44. [DOI] [PubMed] [Google Scholar]
  10. Matsumoto T. K., Hoshino-Shimizu S., Nakamura P. M., Andrade H. F., Jr, Umezawa E. S. High resolution of Trypanosoma cruzi amastigote antigen in serodiagnosis of different clinical forms of Chagas' disease. J Clin Microbiol. 1993 Jun;31(6):1486–1492. doi: 10.1128/jcm.31.6.1486-1492.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Norris K. A., Schrimpf J. E. Biochemical analysis of the membrane and soluble forms of the complement regulatory protein of Trypanosoma cruzi. Infect Immun. 1994 Jan;62(1):236–243. doi: 10.1128/iai.62.1.236-243.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ouaissi M. A., Taibi A., Loyens M., Martin U., Afchain D., Maidana C., Caudioti C., Cornette J., Martelleur A., Velge P. Trypanosoma cruzi: a carbohydrate epitope defined by a monoclonal antibody as a possible marker of the acute phase of human Chagas' disease. Am J Trop Med Hyg. 1991 Aug;45(2):214–225. doi: 10.4269/ajtmh.1991.45.214. [DOI] [PubMed] [Google Scholar]
  13. Pereira J. B., da Cunha R. V., Willcox H. P., Coura J. R. Evoluço da cardiopatia chagásica crônica humana no Sertão do Estado da Paraíba, Brasil, no período de 4,5 anos. Rev Soc Bras Med Trop. 1990 Jul-Sep;23(3):141–147. doi: 10.1590/s0037-86821990000300002. [DOI] [PubMed] [Google Scholar]
  14. Reyes M. B., Lorca M., Muñoz P., Frasch A. C. Fetal IgG specificities against Trypanosoma cruzi antigens in infected newborns. Proc Natl Acad Sci U S A. 1990 Apr;87(7):2846–2850. doi: 10.1073/pnas.87.7.2846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Scharfstein J., Luquetti A., Murta A. C., Senna M., Rezende J. M., Rassi A., Mendonça-Previato L. Chagas' disease: serodiagnosis with purified Gp25 antigen. Am J Trop Med Hyg. 1985 Nov;34(6):1153–1160. doi: 10.4269/ajtmh.1985.34.1153. [DOI] [PubMed] [Google Scholar]
  16. Schattschneider W., Lopes E. R., De Alencar J. E., Bienzle U., Feldmeier H. A comparative study of four serological methods for diagnosis of acute and chronic Chagas' disease in Brazilian patients. Trop Geogr Med. 1992 Jul;44(3):210–218. [PubMed] [Google Scholar]
  17. Schenkman S., Eichinger D., Pereira M. E., Nussenzweig V. Structural and functional properties of Trypanosoma trans-sialidase. Annu Rev Microbiol. 1994;48:499–523. doi: 10.1146/annurev.mi.48.100194.002435. [DOI] [PubMed] [Google Scholar]
  18. Solana M. E., Katzin A. M., Umezawa E. S., Miatello C. S. High specificity of Trypanosoma cruzi epimastigote ribonucleoprotein as antigen in serodiagnosis of Chagas' disease. J Clin Microbiol. 1995 Jun;33(6):1456–1460. doi: 10.1128/jcm.33.6.1456-1460.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Teixeira M. G., Borges-Pereira J., Netizert E., Souza M. L., Peralta J. M. Development and evaluation of an enzyme linked immunotransfer blot technique for serodiagnosis of Chagas' disease. Trop Med Parasitol. 1994 Dec;45(4):308–312. [PubMed] [Google Scholar]
  20. Umezawa E. S., Shikanai-Yasuda M. A., Gruber A., Pereira-Chioccola V. L., Zingales B. Trypanosoma cruzi defined antigens in the serological evaluation of an outbreak of acute Chagas disease in Brazil (Catolé do Rocha, Paraíba). Mem Inst Oswaldo Cruz. 1996 Jan-Feb;91(1):87–93. doi: 10.1590/s0074-02761996000100015. [DOI] [PubMed] [Google Scholar]
  21. Umezawa E. S., Stolf A. M., Zingales B. Trypanosoma cruzi: different surface antigens of trypomastigotes are targets of lytic antibodies. Acta Trop. 1993 Jun;54(1):41–53. doi: 10.1016/0001-706x(93)90067-l. [DOI] [PubMed] [Google Scholar]
  22. Velásquez E., Reyes L., Thors C., Miettinen A., Chinchilla M., Linder E. Autoantibodies give false positive reactions in the serodiagnosis of Trypanosoma cruzi infection. Trans R Soc Trop Med Hyg. 1993 Jan-Feb;87(1):35–35. doi: 10.1016/0035-9203(93)90411-i. [DOI] [PubMed] [Google Scholar]
  23. Wendel S., Gonzaga A. L. Chagas' disease and blood transfusion: a New World problem? Vox Sang. 1993;64(1):1–12. doi: 10.1111/j.1423-0410.1993.tb02507.x. [DOI] [PubMed] [Google Scholar]
  24. Wincker P., Britto C., Pereira J. B., Cardoso M. A., Oelemann W., Morel C. M. Use of a simplified polymerase chain reaction procedure to detect Trypanosoma cruzi in blood samples from chronic chagasic patients in a rural endemic area. Am J Trop Med Hyg. 1994 Dec;51(6):771–777. doi: 10.4269/ajtmh.1994.51.771. [DOI] [PubMed] [Google Scholar]
  25. Yokoyama-Yasunaka J. K., Pral E. M., Oliveira Júnior O. C., Alfieri S. C., Stolf A. M. Trypanosoma cruzi: identification of proteinases in shed components of trypomastigote forms. Acta Trop. 1994 Sep;57(4):307–315. doi: 10.1016/0001-706x(94)90076-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES